Strength
50; 200 mg/1; mg/1
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228046101
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA214091On Market Since
10/5/2021
Pharmacological Classes
Related Drugs
Same classification
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
00093970201•Teva Pharmaceuticals USA Inc.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
00093970205•Teva Pharmaceuticals USA Inc.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
00093970210•Teva Pharmaceuticals USA Inc.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
00378008501•Mylan Pharmaceuticals Inc.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
52817039100•TruPharma LLC
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
52817039110•TruPharma LLC
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
52817039150•TruPharma LLC
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
72888010700•Advagen Pharma Ltd.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
72888010701•Advagen Pharma Ltd.
$0.0724
per EA
CARBIDOPA-LEVODOPA 25-100 TAB
Generic
72888010705•Advagen Pharma Ltd.
$0.0724
per EA